Wanted : a postdoctoral position for the FDD. Title: Exploring the effect of photobiomodulation on brain activity using fMRI and MEG Validity: 1/01/2022 Contact: Dr Malvina Billeres – Malvina.firstname.lastname@example.org More details in the job description
Read the latest news about Clinatec here.
Awarded annually, the Honda Prize is an international distinction that highlights innovative research in environmental technologies. This year, Professor Alim-Louis Benabid will be honored for his discovery of deep brain stimulation (DBS) and its effects on the symptoms of Parkinson’s disease. Professor Benabid continues his innovative work at Clinatec, Edmond J. Safra biomedical research center. […]
Giant of Neuromodulation Award’ Recognizes Benabid’s Pioneering Work In Treating Symptoms of Parkinson’s Disease, Essential Tremor and Dystonia
Professor Alim Louis Benabid received the Breakthrough Prize 2015 from Sergeï Brin, Google Co-Founder and Anne E. Wojcicki, scientist, sêcialized in biotechnologies and genomics.
Third Award this Year Honors His Work in Treating Parkinson’s Disease and Highlights Research at Clinatec to Treat Neurological Disorders
First French Scientist to Win Award Says Successes Point to New Ways to Use Deep Brain Stimulation to Treat Many other Neurodegenerative Diseases.
An Interview with Alim Louis Benabid and Mahlon R. DeLong…
NEWS RELEASE Alim Louis Benabid, Pioneer in Treatment of Parkinson’s Disease, Receives Lasker Foundation Award. Clinatec – The Edmond J. Safra Biomedical Research Center – Chairman Shares Top International Science Honor for Developing Deep Brain Stimulation Technique. GRENOBLE, France – Sept. 8, 2014 – Prof. Alim-Louis Benabid chairman of the board of Clinatec – […]
The first patients enrolled in the clinical trials have benefitted from non-invasive assessments using molecular imprinting, a new diagnostic tool. The Protool device captures key data concerning molecules, proteins, DNA, etc. from parts of the human body that were previously inaccessible.
Clinatec was awarded the Biovision Catalyzer Prize for its “Silicomics”, and innovative technology that enables an early diagnosis and a targeted treatment of neurodegenerative diseases.